Back to company

Faaborg Pharma - IP ApS: Financial statements 2024

CVR: 43517252

Faaborg Pharma - IP ApS (CVR 43517252) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -247,665 and a net result of DKK -895,356. Equity amounted to DKK -1,612,862.

Gross Profit
-247,665 kr.
Profit/Loss
-895,356 kr.
Equity
-1,612,862 kr.
Total Assets
2,899,401 kr.
Employees
0

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Faaborg Pharma - IP ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

Faaborg Pharma - IP ApS publishes interim reportJun 30, 2024

Faaborg Pharma - IP ApS has published its interim report for the period September 12, 2022 – December 31, 2023.

About Faaborg Pharma - IP ApS

Faaborg Pharma - IP ApS is a Danish company of the type Anpartsselskab based in Faaborg, founded in 2022. The company is registered under the industry Leasing af intellektuelle ejendomsrettigheder og lignende produkter, dog ikke ophavsretsbeskyttede værker. The management consists of Jan Knudsen. The company is owned by Faaborg Løve Produkter Holding I ApS. In 2025, the company reported a gross profit of DKK 75,860 and a net result of DKK -678,796 compared with DKK -895,356 the year before. Equity amounted to DKK -2,291,658.

Other financial years